Session # ASD15

Validation of patient-facing digital tool risk stratification of those at risk for hereditary cancer syndrome: The CARE program accurately identifies high risk individuals

Take home points:

1. The purpose of this study was to assess the analytic validity for the CARE platform by determining the accuracy of the digital tool’s execution and interpretation of NCCN guidelines® as compared to certified genetic counselor’s (CGC) interpretation of the same guidelines.
2. The CARE program’s analytic validity was 99.5% (398/400) for identifying individuals who met NCCN® genetic testing criteria.
3. The CARE program accurately identifies individuals who meet NCCN® testing criteria to aid in risk stratification.

• Title: Validation of patient-facing digital tool risk stratification of those at risk for hereditary cancer syndrome: The CARE program accurately identifies high risk individuals
• Authors: Haley Keller; Deepika Nathan; Sarah Siddiqui; Heather Fecteau; Carrie Horton; Carrie Milliard; Robert Pilarski; Devon Thrush; Lukas Lyon; Shannon Kieran
• Conference: NSGC 2023
• Date: Thursday, Oct 19, 2023 4:30pm - 6:30pm